Towards licensing of CP7_E2alf as marker vaccine against classical swine fever-Duration of immunity.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Vaccine

• Publication date

  2012-04-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2012.02.065PMID 22406108
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative evaluation of live marker vaccine candidates "CP7_E2alf" and "flc11" along with C-strain "Riems" after oral vaccination.

  2012cited by this paper
• Development of a highly sensitive real-time RT-PCR protocol for the detection of Classical swine fever virus independent of the 5' untranslated region.

  2011cited by this paper
• Innocuousness and safety of classical swine fever marker vaccine candidate CP7_E2alf in non-target and target species.

  2011cited by this paper
• An update on safety studies on the attenuated "RIEMSER Schweinepestoralvakzine" for vaccination of wild boar against classical swine fever.

  2010cited by this paper
• Classical swine fever: comparison of oronasal immunisation with CP7E2alf marker and C-strain vaccines in domestic pigs.

  2010cited by this paper
• Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization.

  2009cited by this paper
• CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV).

  2007cited by this paper
• Detection of classical swine fever vaccine virus in blood and tissue samples of pigs vaccinated either with a conventional C-strain vaccine or a modified live marker vaccine.

  2007cited by this paper
• Marker vaccine strategies and candidate CSFV marker vaccines.

  2007cited by this paper
• Novel marker vaccines against classical swine fever.

  2007cited by this paper
• Characterisation of the discrepancy between PCR and virus isolation in relation to classical swine fever virus detection.

  2006cited by this paper
• A universal heterologous internal control system for duplex real-time RT-PCR assays used in a detection system for pestiviruses.

  2006cited by this paper
• Assessment of classical swine fever diagnostics and vaccine performance.

  2006cited by this paper
• Virology Journal BioMed Central Commentary International Committee on Taxonomy of Viruses and the 3,142 unassigned species

  2005cited by this paper
• Validation of a real-time RT-PCR assay for sensitive and specific detection of classical swine fever.

  2005cited by this paper
• Classical swine fever virus Strain 'C'. How long is it detectable after oral vaccination?

  2004cited by this paper
• Comparison of Reverse Transcriptase–Polymerase Chain Reaction, Virus Isolation, and Immunoperoxidase Assays for Detecting Pigs Infected with Low, Moderate, and High Virulent Strains of Classical Swine Fever Virus

  2004cited by this paper
• Vaccination against classical swine fever virus: limitations and new strategies

  2004cited by this paper
• An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus.

  2004cited by this paper
• Vaccinology of classical swine fever: from lab to field

  2003cited by this paper
• Clinical signs and epidemiology of classical swine fever: a review of new knowledge.

  2003cited by this paper
• Vaccinology of classical swine fever: from lab to field.

  2003cited by this paper
• Oral immunisation against classical swine fever (CSF): onset and duration of immunity.

  2001cited by this paper
• Classical swine fever: the global situation.

  2000cited by this paper
• Analysis of classical swine fever virus replication kinetics allows differentiation of highly virulent from avirulent strains.

  2000cited by this paper

• Efficacy of GPE- strain live attenuated vaccine and CP7_E2alf strain recombinant live vaccine (marker vaccine) against Japanese epidemic classical swine fever virus isolated in 2019 and DIVA discrimination ability of the marker vaccine.

  2024cites this paper
• Intranasal Inoculation with Classical Swine Fever Virus Provided a More Consistent Experimental Disease Model Compared to Oral Inoculation

  2024cites this paper
• Development of Porcine Monoclonal Antibodies with In Vitro Neutralizing Activity against Classical Swine Fever Virus from C-Strain E2-Specific Single B Cells

  2023cites this paper
• Identification of novel monoclonal antibodies specific for the conserved epitopes in the E2 protein of genotype 2 classical swine fever virus: implication for differential diagnosis

  2023cites this paper
• Comparative Analysis of the Productivity and Immunogenicity of an Attenuated Classical Swine Fever Vaccine (LOM) and an Attenuated Live Marker Classical Swine Fever Vaccine (Flc-LOM-BErns) from Laboratory to Pig Farm

  2021cites this paper
• A Novel E2 Glycoprotein Subunit Marker Vaccine Produced in Plant Is Able to Prevent Classical Swine Fever Virus Vertical Transmission after Double Vaccination

  2021cites this paper
• Assessment of the control measures of the category A diseases of Animal Health Law: Classical Swine Fever

  2021influential citation
• A Critical Review about Different Vaccines against Classical Swine Fever Virus and Their Repercussions in Endemic Regions

  2021cites this paper
• Novel chimeric E2CD154 subunit vaccine is safe and confers long lasting protection against classical swine fever virus.

  2021cites this paper
• Novel Vaccine Technologies in Veterinary Medicine: A Herald to Human Medicine Vaccines

  2021cites this paper
• Pathogenesis of African swine fever in domestic pigs and European wild boar - lessons learned from recent animal trials.

  2019cites this paper
• Virus Adaptation and Selection Following Challenge of Animals Vaccinated against Classical Swine Fever Virus

  2019cites this paper
• Pestiviruses

  2019cites this paper
• A Review of Classical Swine Fever Virus and Routes of Introduction into the United States and the Potential for Virus Establishment

  2018cites this paper
• A decade of research into classical swine fever marker vaccine CP7_E2alf (Suvaxyn® CSF Marker): a review of vaccine properties

  2017cites this paper
• Corrigendum to "Efficacy of E2 glycoprotein fused to porcine CD154 as a novel chimeric subunit vaccine to prevent classical swine fever virus vertical transmission in pregnant sows".

  2017influential citation
• Recombinant Swinepox Virus Expressing Glycoprotein E2 of Classical Swine Fever Virus Confers Complete Protection in Pigs upon Viral Challenge

  2017cites this paper
• Efficacy of E2 glycoprotein fused to porcine CD154 as a novel chimeric subunit vaccine to prevent classical swine fever virus vertical transmission in pregnant sows.

  2017cites this paper
• Classical Swine Fever—An Updated Review

  2017cites this paper
• Classical swine fever vaccines-State-of-the-art.

  2017cites this paper
• Efficacy of Suvaxyn CSF Marker (CP7_E2alf) in the presence of pre-existing antibodies against Bovine viral diarrhea virus type 1.

  2016cites this paper
• Classical and African swine fever: State-of-the-art diagnostics and control measures

  2016cites this paper
• Classical swine fever virus marker vaccine strain CP7_E2alf: genetic stability in vitro and in vivo

  2015cites this paper
• The control of classical swine fever in wild boar

  2015cites this paper
• Pre-registration efficacy study of a novel marker vaccine against classical swine fever on maternally derived antibody positive (MDA+) target animals.

  2015cites this paper
• Classical swine fever virus marker vaccine strain CP7_E2alf: Shedding and dissemination studies in boars.

  2015cites this paper
• Pre-registration efficacy study of a novel marker vaccine against classical swine fever on Maternally Derived Antibody negative (MDA-) target animals.

  2015cites this paper
• Evaluation of an Erns-based enzyme-linked immunosorbent assay to distinguish Classical swine fever virus–infected pigs from pigs vaccinated with CP7_E2alf

  2015cites this paper
• The swine CD81 enhances E2-based DNA vaccination against classical swine fever.

  2015cites this paper
• Design and validation of optimized tools for Classical and African swine fever surveillance and pathogenesis research

  2015cites this paper
• Creation of Functional Viruses from Non-Functional cDNA Clones Obtained from an RNA Virus Population by the Use of Ancestral Reconstruction

  2015cites this paper
• Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypes.

  2014cites this paper
• Differentiation of Classical Swine Fever Virus Infection from CP7_E2alf Marker Vaccination by a Multiplex Microsphere Immunoassay

  2014cites this paper
• Classical swine fever in China: a minireview.

  2014cites this paper
• Comparative analyses of host responses upon infection with moderately virulent Classical swine fever virus in domestic pigs and wild boar

  2014cites this paper
• Efficacy of CSF vaccine CP7_E2alf in piglets with maternally derived antibodies.

  2014cites this paper
• Rescue of the highly virulent classical swine fever virus strain "Koslov" from cloned cDNA and first insights into genome variations relevant for virulence.

  2014cites this paper
• Cytokine and immunoglobulin isotype profiles during CP7_E2alf vaccination against a challenge with the highly virulent Koslov strain of classical swine fever virus.

  2014cites this paper
• Third generation DIVA vaccine towards classical swine fever virus. Efficacy in face of maternal immunity

  2013cites this paper
• [Progress in new-type vaccines against classical swine fever].

  2013cites this paper
• Classical swine fever.

  2013cites this paper
• Third generation DIVA vaccine towards classical swine fever virus. Efficacy in face of maternal immunity

  2013cites this paper
• Approved and experimental countermeasures against pestiviral diseases: Bovine viral diarrhea, classical swine fever and border disease.

  2013cites this paper
• Comprehensive evaluation of the adenovirus/alphavirus-replicon chimeric vector-based vaccine rAdV-SFV-E2 against classical swine fever.

  2013cites this paper
• Two newly developed E(rns)-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies.

  2013cites this paper
• CP7_E2alf oral vaccination confers partial protection against early classical swine fever virus challenge and interferes with pathogeny-related cytokine responses

  2013cites this paper
• [Possibilities and limitations in veterinary vaccine development using the example of classical swine fever].

  2013cites this paper
• Classical and African swine fever in domestic pigs and European wild boar

  2012cites this paper
• Efficacy of marker vaccine candidate CP7_E2alf in piglets with maternally derived C-strain antibodies.

  2012cites this paper
• Identi fi cation of novel monoclonal antibodies speci fi c for the conserved epitopes in the E2 protein of genotype 2 classical swine fever virus: implication for differential diagnosis

  year unknowncites this paper